Review of Two Phase 3 Clinical Programs with Near-Term Readouts PRINCETON, N.J., Oct. 3, 2019 /PRNewswire/ -- Soligenix, Inc. (SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that its Chief Scientific Officer,… Read More..

Long Beach, Calif., Oct. 03, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Emerald Bioscience, Inc. (EMBI), focused on the development of cannabinoid-based therapeutics to address global medical indications, especially those of unmet medical need, today announced that Glauconix Biosciences, Inc. will be presenting biomarker data in human donor tissue related to the… Read More..

VANCOUVER, BC / ACCESSWIRE / October 3, 2019 / The Wonderfilm Media Corporation (TSXV:WNDR)(OTCQB:WDRFF), ("Wonderfilm" or the "Company"), a producer of high-quality feature films and episodic television that offer international appeal, is excited to announce the appointment of PCG Advisory, Inc., a leading investor relations and digital strategies firm, to… Read More..